Charles River Laboratories International, Inc. (NYSE:CRL)

38.19

-0.16 (-0.42%)

Mar 16 - Close

Open
38.38
High
38.48
Low
38.02
Vol.
34.04K
Avg. Vol.
838.60K
Mkt Cap
2.52B
52Wk High
40.14
52Wk Low
23.29
Bid
25.70
Ask
25.74
P/E (Trailing)
21.94
Beta
0.59
Short %
5.60%
Div. Yield
—
Shares
65.89M

After-Hours 38.35   0.00 (0.00%) Mar 16 15:59ET

Company Profile

Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc.

251 Ballardvale Street

Wilmington, MA 01887

United States - Map

Phone: (781) 222-6000

Fax: (978) 658-7841

Website: www.criver.com

CEO: James C. Foster

Employees: 8,000

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Provides solutions that accelerate drug discovery

The Company is a global provider of solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services.

Recent news for CRL

Members owning CRL also own

TXT (33.33%), AGT (16.67%), NSTC (16.67%), EQR (16.67%), TAC (16.67%)

Member sentiment (?)    Neutral

««     MarketGuru Blog network     »»

Recent opinions on CRL

No recent Opinions for CRL

Top members owning CRL

* Average monthly return vs. S&P 500

- Advertisement -